Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes
Article in Journal of Clinical Medicine (January 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in Journal of Clinical Medicine (January 2024)
Article in Human Cell (December 2023)
Preprint in Research Square (September 2023)